IMP3 and Familial prostate cancer: Studies have shown that the high expression pattern of IMP3 predicted a poor prognosis in several kinds of cancers, including muscle invasive bladder cancer [12], sacral chordoma [42], hepatocellular carcinoma [43] and prostate cancer [15, 16].